Creating and distributing additional copies is prohibited without the permission of the publisher. Contact

BNDESPar Makes Biotech Investment

Jan 22, 2013

BNDESPar has agreed to buy a BRL600m ($294m) stake in of GraalBio, a Brazilian biotechnology...

To continue reading please take a free trial, subscribe or login below.

Already have an account?


Subscribe now for unlimited access to all current and archive news, data and market analysis. 


Free trial

Take a free two-week trial now for the latest news, data and market analysis.

Free Trial

LatinFinance Events


Will ABS become more interesting for LatAm borrowers as US monetary policy normalizes?


Printing isn't available for this page.